Yasuhito Uezono Selected Research

G Protein-Coupled Inwardly-Rectifying Potassium Channels

7/2022

Involvement of spinal G-protein inwardly rectifying potassium (GIRK) channels in the enhanced antinociceptive effects of the activation of both μ-opioid and cannabinoid CB1 receptors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasuhito Uezono Research Topics

Disease

32	Neoplasms (Cancer) 06/2022 - 08/2012
20	Pain (Aches) 01/2022 - 05/2004
13	Neuralgia (Stump Neuralgia) 07/2022 - 07/2013
11	Cachexia 01/2020 - 08/2012
10	Anorexia 07/2018 - 11/2012
7	Stomatitis 06/2022 - 09/2013
7	Hyperalgesia 01/2021 - 11/2008
6	Cancer Pain 01/2022 - 01/2014
5	Stomach Neoplasms (Stomach Cancer) 02/2022 - 01/2013
5	Intractable Pain 04/2020 - 03/2014
4	Mucositis 01/2021 - 05/2016
4	Weight Loss (Weight Reduction) 12/2018 - 11/2012
3	Chronic Pain 01/2021 - 11/2008
3	Constipation 01/2020 - 11/2012
3	Breast Neoplasms (Breast Cancer) 01/2020 - 12/2018
3	Peripheral Nervous System Diseases (PNS Diseases) 07/2019 - 01/2014
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022 - 06/2021
2	Cardiotoxicity 01/2021 - 01/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2017
2	Anxiety Disorders (Anxiety Disorder) 01/2020 - 01/2019
2	Inflammation (Inflammations) 01/2020 - 09/2014
2	Heart Failure 01/2020 - 02/2005
2	Atrophy 12/2018 - 11/2015
2	Vomiting 07/2018 - 09/2017
2	Fatigue 01/2018 - 11/2012
2	Dyspepsia (Indigestion) 09/2017 - 01/2015
2	Diarrhea 01/2017 - 09/2013
2	Body Weight (Weight, Body) 01/2017 - 01/2014
2	Ulcer 05/2016 - 01/2015
2	Hypesthesia (Numbness) 11/2015 - 11/2012
2	Ileus 04/2015 - 01/2015
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2015 - 01/2015
2	Gastroesophageal Reflux (GERD) 01/2015 - 11/2009
2	Bone Neoplasms (Bone Cancer) 10/2014 - 01/2014
1	Demyelinating Diseases (Demyelinating Disease) 01/2022
1	Death (Near-Death Experience) 01/2022
1	Hypothermia 09/2021
1	Breakthrough Pain 01/2021
1	Hypertension (High Blood Pressure) 01/2021

Drug/Important Bio-Agent (IBA)

10	Analgesics (Analgesic Drugs)IBA 09/2021 - 01/2014
9	liu-jun-zi-tangIBA 12/2018 - 08/2013
8	Opioid Receptors (Opioid Receptor)IBA 07/2022 - 10/2012
8	Opioid Analgesics (Opioids)IBA 07/2022 - 07/2013
6	Morphine (MS Contin)FDA LinkGeneric 07/2022 - 11/2008
6	Voltage-Gated Sodium ChannelsIBA 01/2021 - 03/2014
6	Pharmaceutical PreparationsIBA 07/2019 - 02/2005
5	Cisplatin (Platino)FDA LinkGeneric 07/2020 - 08/2013
4	Fentanyl (Sublimaze)FDA LinkGeneric 01/2022 - 11/2008
3	Methadone (Dolophine)FDA LinkGeneric 01/2022 - 01/2018
3	EnzymesIBA 01/2020 - 01/2014
3	Proteins (Proteins, Gene)FDA Link 07/2019 - 01/2014
3	GhrelinIBA 01/2017 - 01/2014
3	Adenosine Triphosphate (ATP)IBA 01/2017 - 03/2002
3	gosha-jinki-ganIBA 11/2015 - 09/2013
3	Tramadol (K315)FDA LinkGeneric 10/2015 - 03/2002
3	NeuropeptidesIBA 09/2015 - 01/2007
3	Substance PIBA 04/2014 - 12/2010
2	Therapeutic UsesIBA 09/2021 - 01/2020
2	((3- methoxythiophen- 2- yl)methyl)((2- (9- (pyridin- 2- yl)- 6- oxaspiro(4.5)decan- 9- yl)ethyl))amineIBA 01/2021 - 01/2017
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 01/2017
2	Dinoprostone (PGE2)FDA Link 01/2020 - 09/2014
2	2- (1,3- dimethyl- 2,6- dioxo- 1,2,3,6- tetrahydro- 7H- purin- 7- yl)- N- (4- isopropylphenyl)acetamideIBA 07/2019 - 05/2016
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2019 - 12/2018
2	Pregnanolone (Allopregnanolone)IBA 05/2018 - 09/2014
2	Peptides (Polypeptides)IBA 01/2018 - 08/2013
2	AntiemeticsIBA 09/2017 - 04/2014
2	1-Acylglycerophosphocholine O-Acyltransferase (1 Acylglycerophosphocholine O Acyltransferase)IBA 01/2017 - 01/2014
2	Platelet Activating FactorIBA 01/2017 - 01/2014
2	Fluorouracil (Carac)FDA LinkGeneric 01/2017 - 05/2016
2	Acetic Acid (Vinegar)FDA LinkGeneric 05/2016 - 01/2015
2	Capsaicin (Zostrix)FDA Link 02/2016 - 01/2015
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2015 - 01/2014
2	Lidocaine (Xylocaine)FDA LinkGeneric 03/2015 - 01/2015
2	Small Interfering RNA (siRNA)IBA 10/2014 - 01/2014
2	CatecholaminesIBA 02/2005 - 03/2002
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 07/2022
1	G Protein-Coupled Inwardly-Rectifying Potassium ChannelsIBA 07/2022
1	InterferonsIBA 02/2022
1	Interferon Type IIBA 02/2022
1	AlkaloidsIBA 02/2022
1	tomatidineIBA 02/2022
1	Ketamine FDA LinkGeneric 01/2022
1	Myelin Basic ProteinIBA 01/2022
1	Endothelin A ReceptorIBA 09/2021
1	Local AnestheticsIBA 01/2021
1	Dopamine (Intropin)FDA LinkGeneric 01/2021
1	GTP-Binding Proteins (G-Protein)IBA 01/2021

Therapy/Procedure

18	Drug Therapy (Chemotherapy) 01/2022 - 03/2014
10	Therapeutics 01/2022 - 12/2007
6	Ligation 07/2022 - 01/2017
6	Oral Administration 12/2020 - 02/2014
5	Kampo Medicine (Kampo) 01/2018 - 11/2012
3	Palliative Care (Palliative Therapy) 06/2022 - 11/2012
3	Radiotherapy 01/2022 - 01/2016
2	Analgesia 09/2021 - 03/2002
2	Transplantation 10/2014 - 01/2014
2	Spinal Injections 10/2014 - 01/2014
1	Hematopoietic Stem Cell Transplantation 01/2022
1	Treatment Delay 01/2022
1	Intravenous Administration 01/2022